FOR IMMEDIATE RELEASE
December 07, 2007
|
 |
|
China Indefinitely Postpones Medical Device Import Regulation
|
WASHINGTON, D.C. – AdvaMed President and CEO Stephen J. Ubl released the following statement today regarding an announcement by China’s Administration of Quality Supervision, Inspection, and Quarantine (AQSIQ) and the inspection of U.S. manufactured medical devices:
“AdvaMed welcomes the recent announcement by AQSIQ to indefinitely postpone a regulation known as Decree 95 that would have required inspections of up to 100 percent of all medical device shipments at the port of importation. Such an effort would have seriously delayed patient access to lifesaving and life-enhancing medical technologies.
”We look forward to working with AQSIQ to craft regulations to ensure import safety without creating delays in patient access to medical devices or unnecessarily disrupting our strong trading relationship.”
The full text of the AQSIQ announcement can be found at:
http://www.aqsiq.gov.cn/zwgk/jlgg/jlgkzh/200712/t20071204_56802.html.
# # #
AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. Our members produce nearly 90 percent of the health care technology purchased annually in the United States and more than 50 percent purchased annually around the world. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit
www.advamed.org.